More than 2000 drugs now in cancer immunotherapy raceFox BusinessLONDON, Dec 7 (Reuters) – The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune… Continue reading
More than 2000 drugs now in cancer immunotherapy raceFox BusinessLONDON, Dec 7 (Reuters) – The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune… Continue reading
|
Novel Viral Vectors for Gene Therapy
Genetic Engineering & Biotechnology News Now, however, Venditti’s research is starting to explore other potential cures for the disease—specifically gene therapies. This research has shown real promise in the last few years with the use of new viral vectors for gene therapies that might … |
|
Novel Viral Vectors for Gene Therapy
Genetic Engineering & Biotechnology News Now, however, Venditti’s research is starting to explore other potential cures for the disease—specifically gene therapies. This research has shown real promise in the last few years with the use of new viral vectors for gene therapies that might … |
|
More than 2000 drugs now in cancer immunotherapy race
Reuters Roche Chief Executive Severin Schwan is convinced the mass rush into the hot new field of immunotherapy will lead to multiple disappointments. As the world’s biggest cancer drug company, the Swiss group expects to emerge among a handful of winners but … |